We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Draft Guidance on Tentatively Approved ANDAs
FDA Issues Draft Guidance on Tentatively Approved ANDAs
The FDA released draft guidance Wednesday for companies seeking amendments or final approval for tentatively approved ANDAs — the first guidance to emerge during the partial government shutdown.